prostate cancer
prostate cancer
Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪
Firefly Raises $94 Million to Revolutionize Cancer Treatment
🔥 Firefly secures $94m 💼 to develop antibody conjugates ⚡️ for precision medicines targeting cancer and other diseases. 🌍
Groundbreaking $800m Cancer Partnership Revolutionizes Treatment
🔍 Sorry, the requested page cannot be found. Please go back to the home page. 🏠 AstellasXyphos Kelonia CancerResearch Partnership
Revolutionary Kyverna Cuts CAR-T Production to 3 Days
📰 CAR-T, a gamechanger in cancer treatment, could revolutionize patient access and save lives with Kyverna's 3-day process. 💉🔬
Novartis Revolutionizes Cancer Therapy Production with Automation
📢 Novartis automates new radioligand therapy plant in Indianapolis! Increased supply and timely production for prostate cancer therapy. 👨🔬🤖🏭💉
Novartis Invests $100M to Revolutionize Cancer Therapy
📢 Novartis is investing $100 million in expanding radioligand production in Indianapolis, supporting targeted therapies for prostate cancer. 🏥 🎯 This investment will create 100 new jobs, as Novartis aims to become a leader in radioligand therapy production. 💼
